BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity. 2019

Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Nahda University, Beni Suef, Egypt.

A series of 1,2,4-triazolo[1,5-a]pyrimidine derivatives was designed, synthesized, and screened for their phosphodiesterase (PDE 4B) inhibitory activity and bronchodilation ability. Compound 7e showed 41.80% PDE 4B inhibition at 10 µM. Eight compounds were screened for their bronchodilator activity, where compounds 7f and 7e elicited promising bronchodilator activity with EC50 values of 18.6 and 57.1 µM, respectively, compared to theophylline (EC50  = 425 µM). Molecular docking at the PDE 4B active site revealed a binding mode and docking scores comparable to those of a reference ligand, consistent with their PDE 4B inhibition activity.

UI MeSH Term Description Entries
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014132 Trachea The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. Tracheas

Related Publications

Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
A novel synthesis of 1,2,4-triazolo[1,5-a]isoindolinetrione, 1,2,4-triazolo[1,5-a]pyrimidine and 1,2,4-triazolo[2,3-a]quinazolinedione derivatives and their antibacterial activity.
January 1997, Die Pharmazie,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors.
April 2022, Bioorganic chemistry,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Synthesis and antimicrobial activity of certain new 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
March 2008, Archives of pharmacal research,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
A novel Syk family kinase inhibitor: design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives.
August 2008, Bioorganic & medicinal chemistry,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
March 2008, European journal of medicinal chemistry,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
November 2019, Bioorganic chemistry,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Design, synthesis, crystal structure and in vitro antimicrobial activity of novel 1,2,4-triazolo[1,5-a]pyrimidine-containing quinazolinone derivatives.
May 2021, Molecular diversity,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors.
November 2021, Bioorganic chemistry,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists.
October 2010, Bioorganic & medicinal chemistry letters,
Rehab H Abd El-Aleam, and Riham F George, and Kevin J Lee, and Adam B Keeton, and Gary A Piazza, and Amr A Kamel, and Mahmoud E El-Daly, and Ghaneya S Hassan, and Hamdy M Abdel-Rahman
[1,2,4]Triazolo[1,5-a]pyrimidine derivatives: Structure-activity relationship study leading to highly selective ENPP1 inhibitors.
June 2024, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!